部分原文報道如下：

 

　　Data on antimicrobial resistance (AMR) in zoo notic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by the EFSA and the ECDC and reported in a yearly EU Summary Report. The annual mo nitoring of AMR in animals and food within the EU is targeted at selec ted animal species correspo nding to the reporting year. The 2020 mo nitoring specifically focussed on poultry and their derived carcases/meat, while the mo nitoring performed in 2019 specifically focused on fattening pigs and calves under 1 year of age, as well as their derived carcases/meat. Mo nitoring and reporting of AMR in 2019–2020 included data regarding Salmonella, Campylobacter and indicator E. coli isolates, as well as data obtained from the specific mo nitoring of presumptive ESBL-/AmpC-/carbapenemase-producing E. coli isolates. Additionally, some MSs reported voluntary data on the occurrence of methicillin-resistant Staphylococcus aureus in animals and food, with some countries also providing data on antimicrobial susceptibility. This report provides an overview of the main findings of the 2019–2020 harmo nised AMR mo nitoring in the main food-producing animal populations monitored, in carcase/meat samples and in humans. Wher e available, mo nitoring data obtained from pigs, calves, broilers, laying hens and turkeys, as well as from carcase/meat samples and humans were combined and compared at the EU level, with particular emphasis on multidrug resistance, complete susceptibility and combined resistance patterns to critically im portant antimicrobials, as well as Salmo nella and E. coli isolates possessing ESBL-/AmpC-/carbapenemase phenotypes. The key outcome indicators for AMR in food-producing animals, such as complete susceptibility to the harmo nised panel of antimicrobials in E. coli and the pre valence of ESBL-/AmpC-producing E. coli have been specifically analysed over the period 2014–2020.

 

　　更多詳情參見：https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2022.7209